[ad_1]
This cross-sectional study examines contemporary evidence on the extent to which Medicare beneficiaries with HIV fill older, more toxic antivirals as part of their antiretroviral therapy.
[ad_2]
Source link
[ad_1]
This cross-sectional study examines contemporary evidence on the extent to which Medicare beneficiaries with HIV fill older, more toxic antivirals as part of their antiretroviral therapy.
[ad_2]
Source link